Latest Articles
Leuprolide Acetate Market May See a Big Move | Major Giants- AbbVie, Mylan, Apotex - newstrail.com
Leuprolide Acetate Market May See a Big Move | Major Giants- AbbVie, Mylan, Apotex newstrail.com
Published: Sept. 13, 2025, 11:33 a.m.
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider - SINA HONG KONG LIMITED
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider SINA HONG KONG LIMITED
Published: Sept. 2, 2025, 11:40 a.m.
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 - GlobeNewswire
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 GlobeNewswire
Published: Sept. 2, 2025, 10:32 a.m.
Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate... - Medical Dialogues
Sun Pharma Gets CDSCO Panel Go-Ahead to Manufacture, Market Relugolix, Estradiol, Norethindrone Acetate... Medical Dialogues
Published: July 2, 2025, 11:31 a.m.
Key Trend In The Leuprolide Acetate Market In 2025: Innovative Drug Delivery Formulations Enhance Patient - EIN News
Key Trend In The Leuprolide Acetate Market In 2025: Innovative Drug Delivery Formulations Enhance Patient EIN News
Published: July 1, 2025, 11:02 a.m.
acetate on the uterine telocytes, - ResearchGate
acetate on the uterine telocytes, ResearchGate
Published: March 15, 2025, 6:16 p.m.
The effect of norethisterone acetate on the uterine telocytes, immune cells and progesterone receptors in albino rats - Nature.com
The effect of norethisterone acetate on the uterine telocytes, immune cells and progesterone receptors in albino rats Nature.com
Published: March 15, 2025, 2:19 p.m.
Retraction Note: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial - Reproductive Health
Retraction Note: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial Reproductive Health
Published: March 9, 2025, 9:57 p.m.
SAHPRA Issues Warning on Meningioma Risk with Medroxyprogesterone Acetate Use, Updates Product Information - Devdiscourse
SAHPRA Issues Warning on Meningioma Risk with Medroxyprogesterone Acetate Use, Updates Product Information Devdiscourse
Published: Jan. 17, 2025, 4:01 p.m.
Link copied to clipboard!